Abstracts PAMM 2020

Turning Point Therapeutics Presents Initial Clinical Data From Phase 1 SHIELD-1 Study of Novel MET/SRC/CSF1R Inhibitor TPX-0022 at 2020 EORTC-NCI-AACR Symposium

submitted by montaukwhaler to nsclc [link] [comments]

Pessoal de T.I. aqui já tirou a CNH?

Pessoal de T.I. aqui já tirou a CNH? submitted by urubufedido to brasil [link] [comments]

Pessoal de T.I. aqui já tirou a CNH?

Pessoal de T.I. aqui já tirou a CNH? submitted by urubufedido to antitrampo [link] [comments]

Pessoal de T.I. aqui já tirou a CNH?

Pessoal de T.I. aqui já tirou a CNH? submitted by MatheusKS95 to u/MatheusKS95 [link] [comments]

Samskrit Certificate Course

Samskrit Certificate Course
Central Sanskrit University offers online Certificate Courses on Samskrit Knowledge Systems as per the Article 4.17 of NEP 2020

Admission Open
Enroll Now http://csu.learnsamskrit.online

submitted by learnsamskrit to learnsamskrit [link] [comments]

Discussion Thread: NBC News: President Donald Trump Town Hall - 10/15/2020 | Live - 8:00pm ET

Good evening, and welcome to politics' coverage of the NBC News: President Donald Trump Town Hall!
Tonight's town hall with President Donald J. Trump (R) will feature a conversation between Trump and a group of Florida voters, will be moderated by Savannah Guthrie and is hosted by the Pérez Art Museum in Miami, FL.
The town hall is scheduled for one hour, and will feature questions, on a variety of topics, directly from Florida voters.
As a precaution against COVID-19, the town hall will take place outdoors at the Pérez Art Museum in accordance with guidelines set forth by health officials and consistent with all government regulations.Both Guthrie and the president will be at least 12 feet apart from each other and the audience. The audience will also be socially distanced and required to wear masks, answer a symptoms questionnaire and take a temperature check before entering the outdoor venue. Every NBC News staffer will be tested on site in Miami.source
Both candidates have agreed to participate in the third debate, which is scheduled for Oct. 22 and will be moderated by Kristen Welker of NBC News.
The town hall will begin at 8:00pm ET. You can watch live online on:
You can also follow online via
submitted by PoliticsModeratorBot to politics [link] [comments]


re CAMBRIDGE, Mass., Nov. 10, 2021 /PRNewswire/ -- Nuvalent, Inc. (NUVL), (Nasdaq: NUVL), a biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today reported recent pipeline progress and third quarter 2021 financial results.
"Throughout the third quarter of 2021, we continued to progress our novel portfolio of precisely targeted therapies for patients with cancer. Notably, our first clinical trial of NVL-520, the 'ARROS-1' study, is now open for enrollment of patients with advanced ROS1-positive NSCLC and other solid tumors," said James Porter, Ph.D., Chief Executive Officer at Nuvalent. "We anticipate a robust set of upcoming operational milestones, including the dosing of the first patient in our ARROS-1 study in 2021, the advancement of our parallel lead program NVL-655 into clinical development for ALK-positive cancers, and the expansion of our portfolio with additional internally developed product candidates. With a dedicated, expert team and a strong balance sheet in place, we believe we are well-positioned to achieve the milestones ahead."
Recent Program Highlights
ARROS-1 Phase 1/2 Clinical Trial of NVL-520 Open for Enrollment: Nuvalent has activated multiple U.S. sites to begin enrollment in its ARROS-1 clinical trial, a Phase 1/2, multicenter, open-label, dose-escalation and expansion study evaluating NVL-520 as an oral monotherapy in patients with advanced ROS1-positive non-small cell lung cancer (NSCLC) and other solid tumors. NVL-520 is a novel ROS1-selective inhibitor designed to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of currently available ROS1 tyrosine kinase inhibitors (TKIs). The Phase 2 portion of the ARROS-1 study is designed to support potential registration of NVL-520 in both ROS1-positive patients with NSCLC who are kinase inhibitor-naïve and who have been previously treated with ROS1 kinase inhibitors. Clinical site expansion in the US and EU is ongoing. Preclinical Data Supporting Lead Programs for ROS1-Positive and ALK-Positive NSCLC Presented at 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference: Nuvalent presented new preclinical data at the 2021 AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference further demonstrating that NVL-520 and NVL-655, its parallel lead product candidates, were active against both wild-type and various known resistance variants of ROS1 or ALK, respectively; were brain-penetrant with the potential to address brain metastases; and selectively inhibited their respective targets compared to the structurally related tropomyosin receptor kinase B (TRKB), thereby minimizing the potential for off-target TRKB-related CNS adverse events. The ARROS-1 Phase 1/2 clinical trial of NVL-520 is open for enrollment, and Nuvalent plans to initiate a Phase 1/2 clinical trial of NVL-655 in advanced ALK-positive NSCLC and other cancers during the first half of 2022. Upcoming Investor Conference Presentations
33rd Annual Virtual Piper Healthcare Conference: Dr. Porter will participate in a pre-recorded fireside chat during the 33rd Annual Virtual Piper Healthcare Conference, being held November 30 – December 2, 2021. The fireside chat will be available to registered participants beginning on November 22, 2021, and the webcast will be available in the investor section of the company's website at www.nuvalent.com for 30 days following the presentation. Third Quarter 2021 Financial Results
Cash Position: Cash, cash equivalents and marketable securities were $302.4 million as of September 30, 2021, including net proceeds from the initial public offering completed on August 2, 2021, compared to $10.3 million as of December 31, 2020. Research & Development (R&D) expenses: R&D expenses were $9.1 million for the third quarter of 2021, compared to $3.7 million for the third quarter of 2020. General & Administrative (G&A) expenses: G&A expenses were $3.4 million for the third quarter of 2021, compared to $0.3 million for the third quarter of 2020. Net Loss: Net loss for the third quarter of 2021 was $12.4 million, or $0.39 per share, compared to $4.8 million, or $1.57 for the third quarter of 2020. About Nuvalent Nuvalent, Inc. is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets. Leveraging deep expertise in chemistry and structure-based drug design, we develop innovative small molecules that have the potential to overcome resistance, minimize adverse events, address brain metastases, and drive more durable responses. Nuvalent is advancing a robust pipeline with parallel lead programs in ROS1-positive and ALK-positive non-small cell lung cancer (NSCLC), along with multiple discovery-stage research programs. We routinely post information that may be important to investors on our website at www.nuvalent.com. Follow us on Twitter (@nuvalent) and LinkedIn.
submitted by Aggressive-Truck9141 to stocks2buy [link] [comments]

A thorough DD on $ALRN (Aileron Therapeutics)

What is Aileron Therapeutics & what do they do? * Aileron Therapeutics is a clinical stage company developing a novel medicine, ALRN-6924, to improve the quality of life of cancer patients * Their long-term vision is to protect cancer patients across a variety of chemotherapies for many different cancer indications. * Aileron is exploring collaboration opportunities regarding ALRN-6924 for chemoprotection, and in other areas where Aileron’s proprietary platform of stabilized cell-permeating peptides can be applied such as targeted protein degradation.
What is ALRN-6924? * Their Pipeline drug is intended for all cancer patients * ALRN-6924 is a first-in-class dual MDM2/MDMX inhibitor * currently being evaluated in a Phase 1b/2 clinical trial to protect cancer patients against chemotherapy-induced toxicities * They believe that treatment of patients with ALRN-6924 can reduce the toxic effects of chemotherapy while having no adverse effect on the anti-cancer activity of chemotherapy against p53-mutant tumor cells.
How Does ALRN-6924 Work? * ALRN-6924 is a decoy that mimics p53 and selectively binds to MDMX + MDM2, activating p53 to induce cell cycle arrest * In cells with normal p53, ALRN-6924 activates p53 by blocking MDM2 and MDMX * Activated p53 initiates cell cycle arrest * Cells that are in cell cycle-arrest are less sensitive to chemotherapy * ALRN-6924 is only being developed for patients with p53-mutant cancers, which represent 50% of all cancer patients. * Links showing what I said in terms of how ALRN-6924 works & more information: Link 1 Link 2 Link 3
Q1 Financials & Highlights * Cash, cash equivalents and investments as of March 31, 2020 were $12.7 million. * The Company has determined to focus its efforts on the development of ALRN-6924 as a chemoprotective agent, and does not plan to advance development of ALRN-6924 for any other program at this time * The Company believes that its cash, cash equivalents and investments as of March 31, 2020 will be sufficient to fund its operations and capital expenditure requirements into the first quarter of 2021. * Research and development expenses for the three months ended March 31, 2020 were $4.1 million, compared to $4.2 million for the three months ended March 31, 2019 * the Company expects that its quarterly expenditures on research and development will be lower for the remainder of 2020 as compared to the first quarter of 2020. * Net loss was $6.7 million for the three months ended March 31, 2020, compared to $7.2 million for the same period in 2019. * Based on the preliminary data from the Phase 1b trial, and historical rates of these toxicities in SCLC patients treated with topotecan, Aileron believes that ALRN-6924, when dosed before chemotherapy may have a chemoprotective effect on toxicities such as severe anemia and thrombocytopenia. * The Company plans to commence the schedule optimization part of the Phase 1b trial in June 2020. * The Company currently plans to report top-line final data for the dose optimization part of the trial and data for the schedule optimization part of the trial in the fourth quarter of 2020 Links to Q1 Financials/highlights: Link 1 Link 2
Recent events to positively impact Q2-Q4 * On October 29th, 2019 $ALRN Announced new data at the 2019 AACR-NCI-EORTC Conference from nonclinical studies in which ALRN-6924, a dual inhibitor of MDM2 and MDMX, prevented chemotherapy-related toxicities in cellular studies and mouse models of cancer * nonclinical results show that ALRN-6924 significantly reduces the toxic effects of chemotherapy in normal, healthy bone marrow cells and gastrointestinal tissues * On May 27th 2020, $ALRN Announced the expansion of one of the dose levels in the dose optimization part of its Phase 1b/2 clinical trial evaluating ALRN-6924 as an agent to protect patients with small cell lung cancer * Results emerging from the third dose level support the data observed with the previous two cohorts, where we observed a protective effect of ALRN-6924 for severe anemia and severe thrombocytopenia when compared to historical rates of those toxicities in SCLC patients treated with topotecan * On June 1st 2020, $ALRN Announced positive interim data from the open-label Phase 1b dose optimization part of its ongoing Phase 1b/2 clinical trial. * A protective effect against severe chemotherapy-induced anemia and thrombocytopenia was observed across all dose levels as compared to historical controls * Across all three dose levels, no patients experienced febrile neutropenia or NCI CTC Grade 3/4 nausea, vomiting, diarrhea or fatigue, which are severe toxicities commonly observed with topotecan-treatment in this patient population * On June 4th 2020, $ALRN Announced the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $1.10 per share, for aggregate gross proceeds of $10.0 million * In addition, Aileron has granted the underwriter a 30-day option to purchase up to 1,363,636 additional shares of common stock at the public offering price * The offering is expected to close on June 8, 2020
Corporate Presentation Highlights * ALRN-6924 Has Demonstrated Chemoprotection in Non-clinical Studies: * induced cell cycle arrest in human bone marrow cells in vitro * protected in dose- & schedule-dependent manner against topotecan-induced neutropenia and carboplatin/taxol-induced thrombocytopenia in vivo * Observed protection against gastrointestinal toxicity of chemotherapy in vivo *Link to the Corporate Presentation
Risks/negatives of the business * As found on their recent 10-Q & 10-K SEC Filings: * "We will need substantial additional funding to continue our operations. If we are unable to raise capital when needed, we may be forced to delay, reduce and/or eliminate our research and drug development programs, reduce headcount, and future commercialization efforts, or take other actions that could adversely affect our business." * "d investments as of the date of this Quarterly Report on Form 10-Q will be sufficient to enable us to fund our current operations for at least 12 months from the date of issuance of the financial statements included in this Quarterly Report on Form 10-Q...We plan to seek to address this condition through the sale of common stock in public offerings and/or private placements, and through other capital sources, including collaborations with other companies or other strategic transactions." * "We are dependent on the success of our lead product candidate, ALRN-6924, which is currently in multiple clinical trials. Our clinical trials of ALRN-6924 may not be successful. If our trials prove unsuccessful or if we are unable to obtain approval for and commercialize ALRN-6924 or experience significant delays in doing so, our business will be materially harmed" * "We are pursuing the development of ALRN-6924 in combination with other approved therapeutics. If the FDA revokes approval of any such therapeutic, or if safety, efficacy, manufacturing or supply issues arise with any therapeutic that we use in combination with ALRN-6924 in the future, we may be unable to further develop and/or market ALRN-6924, or we may experience significant regulatory delays, and our business could be materially harmed." * "Even if any of our product candidates receive marketing approval, they may fail to achieve the degree of market acceptance by physicians, patients, healthcare payors and others in the medical community necessary for commercial success." * "We rely on third parties to conduct our clinical trials and some aspects of our research and preclinical studies, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research and studies" * "We may enter into strategic collaborations for the development, marketing and commercialization of ALRN-6924 and our other stabilized cell-permeating peptide product candidates. If those collaborations are not successful, the development, marketing and/or commercialization of our product candidates that are the subject of such collaborations would be harmed." * "If we fail to regain compliance with the requirements for continued listing on the Nasdaq Capital Market, our common stock could be delisted from trading, which would adversely affect the liquidity of our common stock and our ability to raise additional capital or enter into strategic transactions." * They have until September 2020 to reach compliance ** Links to the SEC Filings so you can more in-depth & read other info on the risks section: 10-Q & 10-K
Important upcoming dates/events * Dose & schedule optimization will be announced Q2 of 2020 * Topline Data Results will be announced Q4 of 2020
Target price/forecasts * CNN Money sets the target price at a median of $5 with a high of $8 * TipRanks sets it as a strong buy with a target price of $5 * NASDAQ website sets it as a strong buy with a target price of $5 * Wall Street Journal sets the median target price at $5 with a high of $8
SEC Filings/documents I highly suggest you read! * 10-Q * 10-K * Corporate Presentation * First quarter highlights * June 1st webcast
Final thoughts/comments * Despite this company having it's risks, as all companies do, I personally feel good that this one will reach or at least come close to their target price * I feel that way due to the recent clinical trial result, they have been nothing but positive and the people taking part of the trials have not had any adverse effects so far. * If the Topline data is solid when it is announced in Q4, that will be very positive for the stock's price. * If ALRN continues to prove it's successful & gets FDA approval, this drug can easily be seen almost as a necessity for those with cancer as this drug's intention is to prevent the toxicity effects caused by chemotherapy, not only that, but the specific mutant cell they are Targeting is in 50% of all cancers. * That being said, ALRN-6924 has a huge market potential if it continues to be as successful as these clinical trials are proving to be. * Anyways, for me, I'll be purchasing a couple hundred shares and hold it through Q4 when the Topline Data is announced.
Remember everyone, what I write & say is my opinion and you should never take it as a fact. That's why I urge everyone and will always do so in every single post to please extend my DD by doing your own by reading everything I've attached and looking into the company themselves. I want to make sure you all are informed before making a decision and never act blindly.
I hope that I have been able to help out with this post & with all my other posts in anyway possible. Hopefully you've been able to learn how to improve your DD or at the very least, I hope I've been able to provide a great read lol
Anyways, I hope Everyone is having a good weekend! Take care :)
submitted by PradoMV96 to EducatedInvesting [link] [comments]

Oncotarget: Participating in the AACR 2021 Annual Meeting

The American Association for Cancer Research (AACR) organizes an annual meeting program covering some of the most recent discoveries in cancer research. The conference aims to highlight work from the best minds in research and medicine from institutions all over the world. Oncotarget, exhibited by its publisher Impact Journals, will be participating virtually at the AACR Annual Meeting this year.
Visit the Oncotarget website: https://www.oncotarget.com/
Visit the Impact Journals website: https://www.impactjournals.com/
As of June 2020, Scopus released their latest 2019 Journal Rankings on Oncology. Oncotarget is among their highest rated (Q1) journals and ranked number one in total citations in oncology. The journal has published outstanding papers and reviews by authors including Bert Vogelstein, Peter K. Vogt, Pier Paolo Pandolfi, Arnold J. Levine, Brian Druker, and Carol Prives. Founding Oncotarget Editorial Board members include Nobel Laureates Andrew V. Schally and Gregg L. Semenza; Lasker Award recipients Alexander Varshavsky, Brian J. Druker, and Gregg L. Semenza; and 16 members of the US National Academy of Sciences. Oncotarget is indexed and archived in PubMed, PubMed Central, Scopus, EMBASE, and META (Chan Zuckerberg Initiative). The 2021 AACR conference, a two-week online event, will take place from April 10-15 and May 17-21, 2021. Topics include population science and prevention, cancer biology, translational and clinical studies, survivorship, and advocacy. In 2019, Oncotarget participated in the AACR Annual Meeting at the Georgia World Congress Center in Atlanta, Georgia, USA, and "AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics," at the Hynes Convention Center in Boston, Massachusetts, USA. The total registration count from the 2019 AACR Annual Meeting was over 21,000—nearly 16,000 of which were scientific attendees from all over the world. Follow the Oncotarget Twitter account (@Oncotarget) for live updates about the conference using the #AACR21 hashtag.
About Oncotarget: Oncotarget is a bi-weekly, peer-reviewed, open access biomedical journal covering research on all aspects of oncology. To learn more about Oncotarget, please visit https://www.oncotarget.com or connect with us:
SoundCloud - https://soundcloud.com/oncotarget
Facebook - https://www.facebook.com/Oncotarget/
Twitter - https://twitter.com/oncotarget
Pinterest - https://www.pinterest.com/oncotarget/
Reddit - https://www.reddit.com/useOncotarget/
Oncotarget is published by Impact Journals, LLC please visit https://www.ImpactJournals.com or connect with @ImpactJrnls
Media Contact
[email protected]
submitted by Oncotarget to Oncotarget [link] [comments]

Weekend (24-25 October 2020) Penny Stock News (Just The Headlines) and Pre-Market Watch List/Earnings for 26 October 2020

Weekend (24-25 October 2020) Penny Stock News
$ALRN Aileron Therapeutics Announces Proof-of-Concept Clinical Data from Ongoing ALRN-6924 Phase 1b Trial Presented in Late-Breaking Presentation at the EORTC-NCI-AACR Annual Symposium
$EPIX ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium
$LLIT #Newegg Lianluo Smart Limited and Newegg Inc. Announce Entering into Merger Agreement
$LLIT Lianluo and Newegg Announced Merger Agreement on Saturday; Newegg's Current Stockholders will Own ~ 99.02% of Combined Company
$SYRS Syros Presents Initial Data from Phase 1 Clinical Trial of SY-5609, Its Selective Oral CDK7 Inhibitor, at EORTC-NCI-AACR Meeting

Morning Watch List for 26 October 2020
These Stocks Either Ended Friday With Momentum or Got News Over The Weekend


Do your own due diligence first, do not just enter blindly because someone suggested it to you. If you do not want to learn how to be a trader, please do not try to be a trader. Thank you and I wish you all good luck.

Penny Stock Earnings for 26 October 2020
After Hours

Source (For The Best Stock Calls/Info)
Source (For The Best Stock Calls/Info)
submitted by TheTrueMarketMaker to pennystocks [link] [comments]

HAUS-KEEPING (Independence Day Edition)

The handy-dandy Cliff Notes version to what’s been happening in our sub recently! (a collaborative effort from your moderator team, we hope you enjoy!)
Mod note: As you may have seen, we have decided as a team to reduce Haus-Keeping to once a week for the near future. This was a tough decision and we hope that you all understand. Please continue to interact with each other when and in whatever ways you can.
Have a happy and safe 4th of July!!


u/natalicious-keto has a fun way to check herself
I rub my hands all over the basil because it smells good and hey if I can smell the summery scent of basil, I don't have one of the symptoms of COVID.
She also sums up plans many of us have this long holiday weekend:
Gonna grill and chill!
u/GFEmmers returns feeling much better
I feel like the old me for the first time in almost a year. Tracking? Easy! Fasting? No problem! Keeping calories in check? Of course! Suddenly the ease that I used to have has all returned.
u/2boredtocare is taking on July!
it's going to be a strong month. There is no option for me now but to get my ass back in gear, or face having to fashion clothing out of bedsheets, all toga style.
u/thrashnsass taunting us with her tales of delicious food
If I was a good keto bitch, I'd take pictures of my food adventures. But I'm a hungry keto bitch and I don't think that y'all want pictures of an empty plate.
u/pm-me-seinfeldquotes on dealing with a stressful week
I am keeping my chin up and doing my best to see the good. There are always brighter days ahead.
On another note, she also shares:
meat is my love language

Hot Topics:

In case you missed it, the July 2020 Goal Post is up (thank you u/Trixiekixx).
u/zengal108 wants to know if you have relapse dreams about eating carbs. Share your amusing dreams in her thread.
u/bookstoreamnesia wants to talk coffee creamer substitutes. Coffee addicts, this is your time to shine and share your wisdom!
u/radiant_atmosphere is looking for suggestions for Salty Snacks that are keto friends. Let her know your favorites.
u/littletoe76 is having her wisdom teeth out and is looking for your suggestions for soft keto foods.
And just a friendly PSA…. Hamilton is finally out on Disney+

Biggest Disappointments:

u/mouse_is_watching had an unfortunate counter protest incident on her island community over the weekend. She talks about it in detail in the daily here.
u/natalicious-keto was in limbo waiting on her buffalo exchange payment for her second batch of clothes she got rid of. This is extra sucky because she has also had issues with her homeowners insurance. Frustrating!
u/gillyyak was excited to be able to safely return to the gym with the new guidelines (mask wearing especially) only to find that it was not only not enforced at the gym, but not required. She had to cancel her gym membership and skip out on her long awaited gym workout.
I can't risk myself in an atmosphere like that, AND I WANNA GO BACK TO THE GYM!!!
u/checkthelistz had a bra fail
I bought horrible bras via the internet. They are now in Goodwill's hands. Fingers crossed they will go to a good boob home.

Food Porn:


WE’VE REACHED OVER 4,300 MEMBERS! Let’s celebrate - our community is growing in numbers and awesomeness.


June was my ketoversary and I forgot to post. It’s been an amazing year and I’m 82 lbs lighter. I’ve gone from a size 20 to a size 10 which blows my mind!
Ok. Today is the day. I will regain control of what I'm eating.
u/snowfarts also says no to the temptations trying to make her binge eat
but I told myself no and took my happy ass home!
submitted by KetoKitsune to xxketo4u2 [link] [comments]

Top sàn forex uy tín trên thị trường forex ở việt nam

Top sàn forex uy tín trên thị trường forex ở việt nam

Exness – Sàn forex uy tín, Ông vua về Nạp/Rút cho trader Việt

Exness là một broker có lịch sử hoạt động trong khoảng năm 2008 , là một trong những sàn forex uy tín hoạt động ở việt nam. Đến tháng 12 năm 2018, khối lượng giao dịch hàng tháng của khách hàng đạt 348,4 tỷ đô la Mỹ. Và số lượng nhà thương lượng đang hoạt động của exness trên khắp thế giới đã vượt quá 50.342 người. Hiện tại, Tập đoàn Exness cung ứng hơn 120 sản phẩm đàm phán vốn đầu tư để thương lượng. Với một trong những loại khớp lệnh hữu hiệu nhất trên thị phần và mức chênh lệch siêu hẹp cho các cặp tiền tệ chính.
Năm 2020 sàn Exness cũng mới giành thêm những danh hiệu: doanh nghiệp môi giới ngoại hối minh bạch nhất năm 2020 , và đơn vị môi giới ngoại ăn năn thế giới của năm .

Fxpro – Sàn forex uy tín, nhãn hàng môi giới đẳng cấp toàn cầu.

Fxpro là một Broker thành lập trong khoảng 2006, và tham gia vào thị phần việt nam trong khoảng 2010. Kể bắt đầu từ xây dựng thương hiệu, FxPro đã mở mang thành công để đáp ứng khách hàng bán lẻ và các đơn vị tại hơn 150 quốc gia. Và fxpro vẫn đang trên đà phát triển tăng trưởng. Nhắc đến Fxpro thìa là đề cập đến một tượng đài trong sàn forex uy tín nhất thế giới bởi đây là 1 nhãn hàng môi giới đẳng cấp toàn cầu.

XM – Sàn forex uy tín và rất lừng danh trên thế giới

XM Broker thành lập từ 2009. Với hơn hai.500.000 quý khách nói kể từ thành lập năm, Trader tới trong khoảng hơn 100 quốc gia, 25+ phương thức trả tiền an toàn. Ngày nay, XM đã lớn mạnh trở nên một công ty đầu tư quốc tế to và tăng trưởng. Trở nên một người dẫn đầu thị phần thực thụ. Với một Thống kê tìm kiếm khủng khiếp trên mạng internet. Để thấy XM rất nức tiếng và được ưa thích trên thế giới, XM thực thụ là 1 sự chọn lựa an toàn cho quyết định đàm phán của các bạn.

IC Markets – nhà cung cấp Forex uy tín hàng đầu toàn cầu đến trong khoảng Ú

IC Markets là một Broker chuyên về thương lượng ECN tới trong khoảng Úc. Ưu điểm của Broker này là những phương pháp ưu việt, cộng tác với những nhà sản xuất thanh khoản bậc nhất thế giới để tiến hành những lệnh nhanh hơn. Sàn IC Markets là sàn mà cực nhiều trader lựa chọn, bởi thương lượng nhanh và khớp lệnh rất khả quan. Đông đảo trader sẽ không cảm nhận được độ trễ khi thương lượng trên IC markets.

Hotforex – Sàn forex hàng đầu toàn cầu về đàm phán forex trong khoảng năm 2010

Hotforex có mặt trên thị trường năm 2010, là 1 broker đi đầu trong việc tạo ra những giải pháp thương lượng cho quý khách như quỹ PAMM hay nhà sản xuất sao chép HF Copy . Thêm vào đó, Hotforex cũng đều đặn đơn vị những cuộc thi và sự kiện hơi thú vị cho khách hàng.
Đây là 1 số gợi ý về những sàn forex uy tín nhất việt nam trên thị phần tài chính. Hi vọng những kiến thức này sẽ phần nào giúp bạn hiểu rõ hơn về thị phần cũng như các sàn giao dịch Forex.
submitted by Huyenmaiforex to u/Huyenmaiforex [link] [comments]

Sàn tiền ảo nào uy tín nhất 2021 trong thị trường trade Coin

Với trường hợp các sàn Forex lừa đảo nhiều như hiện nay trên thị trường thì việc chọn lựa được sàn Forex uy tín là điều thiết yếu nhất cho các người nào đầu cơ vào kênh này. Do vậy bản thân những nhà đầu tư, đặc thù là người mới cần phải biết rõ và nắm các kiến thức cơ bản để việc đầu cơ hiệu quả, chuyên nghiệp hơn. Và để có thông tin về các sàn Forex thì không nên bỏ lỡ Phân tích sàn tiền ảo nào uy tín mà Infofinance.vn giới thiệu dưới đây.

Thực trạng sàn Forex lừa đảo hiện nay

Hiện nay kế bên các sàn phân phối Forex uy tín, sàn Forex hoạt động có giấy phép thì có rất nhiều sàn phân phối lừa đảo, làm giả giấy phép hoạt động dưới mọi hình thức để đi lừa đảo. Và vấn đề này ngày càng đa dạng, những dụng cụ truyền thông liên tiếp cảnh báo và sắm ra những sàn này để mọi người có thể tránh xa.
Phương thức lừa đảo của những sàn thực ra rất dễ nhận diện, đa số các sàn mới mà hoạt động theo hiểu mở hội thảo, đi lôi kéo người người kia tham dự vào sàn. Và mọi người quan tâm khi mà đi vào một hội thảo giới thiệu về sàn, về đầu cơ tiền ảo hay Forex nào ấy là cốt yếu là người già, sinh viên, phụ nữ…thì chuẩn xác tầm 80% là sàn đang có vấn đề. Bởi các sàn chuyên nghiệp họ khi công ty hội nghị là để giới thiệu về Công trình nào đó mà thôi và được tiến hành rất chuyên nghiệp.


Sàn XTB ra đời trong khoảng năm 2002, là nhà môi giới ngoại ăn năn Đầu tiên tại Ba Lan, hiện là sàn phân phối Forex hàng đầu thị phần. Sàn được cấp giấy phép Cơ quan quản lý cấp phép bởi FCA (Anh), CySec (Cyprus), KNF (Ba Lan), IFSC ( Belize) và XTB có 13 văn phòng thế giới, bao gồm: Anh, Ba Lan, Đức, Pháp và Chile.
Như thế nên xét về độ uy tín và an toàn thì XTB luôn nằm trong top đầu Đánh giá của thị trường, kế bên sản xuất các sản phẩm Forex thì sàn còn cung ứng nhiều sản phẩm đàm phán khác như chỉ số, vàng, kim loại, tiền ảo, cổ phiếu. XTB được niêm yết trên sàn chứng khoán Warsaw (Ba Lan) với tên phần đông là X-Trade Brokers Dom Maklerski SA, bảo đảm tính minh bạch về tài chính.X
xem thêm : cách nạp tiền sàn CoinEx
thông báo về sàn:
Đòn bẩy
có mặt trên thị trường
Giấy phép
FCA (Anh), CySec (Cyprus), KNF (Ba Lan), IFSC ( Belize)
Khớp lệnh
Sàn ECN, Non-Dealing Desk
nền tảng thương lượng
MT4, xStation5
Ưu điểm đàm phán Forex tại sàn XTB:
tuy thế với sàn XT thì ko có tương trợ CopyTrade và PAMM/MAM, hiện nay chỉ sản xuất 1 account độc nhất nên người mới hay chuyên nghiệp cũng sẽ thương lượng cùng 1 account sẽ gây cạnh tranh và bất luôn thể cho nhà đầu tư ít kinh nghiệm.

Sàn IC Markets

IC Markers là sàn phân phối tới từ Úc, ra đời vào năm 2007 và được cấp phép bởi các cơ quan điều hành như ASIC, FSA. Sàn IC Markets hoạt động trung gian kết nối theo mô phỏng Non Dealing Desk, tức là sẽ kết nối nhà đầu tư với đối tác thanh khoản tiền tệ như ngân hàng, tổ chức tín dụng nên ko có trường hợp ấp ủ lệnh hay bấ kỳ vấn đề gì.
Về ưu điểm lúc đàm phán Forex sàn ICMarkets:
tuy thế thủ tục mở tài khoản của sàn tương đối phức tạp và mất nhiều thời gian, với cá nhân mới thì gặp phổ thông cạnh tranh. Đây là sàn giao dịch thích hợp cho các nhà đầu cơ có kinh nghiệm, số tiền tối thiểu tương đối cao lúc đàm phán.

Sàn XM

XM ra đời từ năm 2009 tại Síp và Úc, là thành viên của Trading Point of Financial Instruments UK Ltd – một doanh nghiệp lớn ở Vương Quốc Anh. Có hội sở hoạt động tại Síp và Úc, nơi có đa dạng sàn môi giới uy tín đang hoạt động. XM được những cơ quan quản lý cấp phép hoạt động FCA (Anh), CySEC (Síp), ASIC (Úc), IFSC (Belize).
Về ưu điểm khi giao dịch Forex sàn XM
tuy nhiên vẫn còn một vài điểm cần chú ý lúc giao dịch Forex trên sàn XM ấy là mở tài khoản mất hơi nhiều thời kì và quy trình hơi phức tạp.

Sàn Exness

xây dựng thương hiệu trong khoảng năm 2008, cho đến nay sàn Exness đã xây dụng được thương hiệu cho bản thân mình. Có hội sở hoạt động tại Síp, được những cơ quan điều hành như FCA, CySEC, FSA cấp phép hoạt động. Đây là một trong những đại lý phân phối Forex lớn, mang tới phổ biến giải thưởng từ những công ty bậc nhất thế giới như tạp chí World Finance Media.
Về ưu điểm khi giao dịch Forex sàn Exness:
Chính vì thế ví như để đầu cơ Forex, muốn tậu tới nơi có phổ biến cặp tiền nhất thì vững chắc mọi người phải chọn Exness.

Sàn Avatrade

Avatrade xây dựng thương hiệu từ năm 2006 tại Ireland, là một đại lý phân phối Forex hàng đầu thị phần hiện nay. Được cấp phép bởi các cơ quan điều hành hàng đầu toàn cầu :
Ưu điểm thương lượng của sàn Avatrade
tuy vậy sàn vẫn có 1 vài tránh được mọi người cần quan tâm đấy là: phương tiện nghiên cứu còn kém, tương trợ qua điện thoại chậm và không linh hoạt, điều hành account mất phí và ko hoạt động cũng mất phí.

Sàn CMTrading

CMTrading là nhãn hàng hoạt động dưới sự điều hành của BLACKSTONE Marketing SA (PTY) LTD. Công ty này là một trong các nhà môi giới ngoại hối hận thông minh nhất toàn cầu và là nhà môi giới to nhất ở Nam Phi. CM được điều hành bởi FSCA ở Nam Phi và có trụ sở chính tại Seychelles. Được nhận phổ biến giải thưởng, nổi trội là Nhà môi giới vốn đầu tư tốt nhất ở Châu Phi 2019 và 2020.
Ưu điểm đàm phán Forex sàn CMtrading:
tuy thế sàn này ko được quy định bởi FCA, ngôn ngữ tương trợ tránh được và hoạt động phần lớn ở nước ngoài ko hoạt động ở Việt Nam.
Để biết được đâu là sàn giao dịch tiền ảo phù hợp với bạn, hãy xem thêm tại bài viết về các loại tiền ảo tiềm năng mà chúng tôi đã tổng hợp
submitted by nguyenhoai12 to u/nguyenhoai12 [link] [comments]

Exchase - an overview of the revolutionary fintech ecosystem.

Exchase is a trading platform that combines a crypto exchange, social trading, binary options, a payment system, and an exchange service into a single ecosystem.
Our international team consists of specialists from various fields: developers, traders, financiers, as well as marketers. Using our unique high-tech solutions, we have combined into one platform many popular services provided by several players in the crypto market and the classic fintech market. Thus, having one account for all these services, users save a significant amount due to the circulation of funds when using them, as the platform does not charge a commission for the transfer of these funds.
As part of the crowdsale campaign Q4 2020 - Q1 2021, 200 million EXSE tokens of the ERC-20 standard will be issued. These emissions will be fixed, and to better maintain the EXSE level, in agreement with the investor community, tokens will be burned at a certain frequency. In addition, the tokens used by traders to reduce trading commissions are bound to be burned. EXSE tokens, apart from performing their basic function as an investment object, will allow their holders to save commissions when carrying out trading operations on the Exchase platform within four years of launch, as well as receive bonuses from referrals.
We are always open for cooperation, forging new contacts and strengthening old ones.
For cooperation, please write [email protected]
Planned launch dates for the Exchase ecosystem services:
Crypto exchange
A trading scheme has already been launched - model B book. The A book model is in beta testing with an expected launch date in the second quarter of 2021.
Margin trading.
The margin trading option is currently in beta testing. The planned launch date is in the first quarter of 2021.
Token Listing
The planned launch date for the placement of third-party tokens on the Exchase platform in the first quarter of 2021.
Crypto wallet
The expected launch of a wallet for storing users' crypto assets in the fourth quarter of 2021.
Crypto games
Implemented and are in the final stages of debugging a crypto game with the EXC token mining system.
Money Transfer System
The Exchase platform is integrated with its own money transfer system (crypto, fiat). For fiat, three flows are supported: bank transfer, cash pickup and mobile money. The money transfer system has already been implemented by our development team. At the moment, it is in beta testing. The planned launch date is Q2 2021.
Binary Options
In addition to the classic exchange trading of fiat and crypto assets, the Exchase platform provides a Binary Options service, the operating rules of which are much simpler and more intuitive understandable for an inexperienced user. Binary options have much more in common with gambling than with trading itself - especially with its advanced forms. You are just as involved in the analysis of market events as in exchange scenarios, but the process of interaction itself comes down to you solely to predict a "bull" or "bear" trand (like in a casino where you bet on a certain color). The Binary Options has already been implemented by our development team. At the moment, it is in beta testing. The planned launch date is Q1 2021.
Social Trading
The Exchase platform provides the feature of subscribing to masters (PAMM managers), in which transactions on behalf of your account will be carried out by the core of the exchange by copying transactions of more professional traders, who are deducted for this a small commission. This is a unique chance for absolute newcomers to trading to enter the industry and benefit from their investments.
Decentralized exchange
The DEX exchange model has already been developed and is in beta testing. The planned launch date is the second quarter of 2021
OTC transactions
The launch of OTC trading on the Exchase platform is scheduled for the fourth quarter of 2021
Crypto loans
The system of loans secured by crypto assets is scheduled to be launched in the fourth quarter of 2021
Based on current market problems, our trading platform will have the following set of solutions:
It should be noted that the cryptocurrency market underwent a huge increase not only in trading volume but also in the introduction of tools familiar to ordinary traders for making profits. Our platform will support trading futures contracts. This solution provides more opportunities to make money and attracts many traders to the platform.
Spot trading:
In addition to futures trading, spot trading will be added. This type of trading is the most popular and familiar to the trading audience, as well as the most reliable, fast and simple.
Margin trading:
Trading on margin is a requirement for any modern exchange looking to compete with big players. Therefore, we consider it mandatory to add this type of trading to our platform.
Anonymous instant exchange:
It should not be forgotten that cryptocurrencies were created to provide greater anonymity. Any merchant who wants to make an instant anonymous exchange can do so using our service.
Decentralized exchanges:
Not everyone trusts exchanges, which means that it is necessary to provide opportunities for decentralized exchanges to those who are very concerned about the safety of their funds.
Token Details
Name: EXSE token
Standard: ERC20
Symbol: EXSE
For sale: 1,000,000 EXSE
General information about the first round
From: 15 Dec 2020 (12:00 AM GMT)
Tokens for sale: 1,000,000 EXSE
Ended: 25 Dec 2020 (12:00 AM GMT)
Min. number of transactions: 50 EXSE / 0.02 ETH
Done via smart contract: Ethereum blockchain
Decimal: 18
Token exchange rate: 1 EXSE = 0.0004 ETH
Max. Amount collected: 400 ETH
The Use of Funds of The First Round
50% : Platfrom develompent
15% : Legal and bank accounts
15% : Obtaining a license to work with virtual assets (cryptocurrency license).
14% : PR and marketing
6%: Operating expenses
Dec, 2020 - Launched a cryptocurrency exchange based on the B-book model Jan, 2021 - Opening bank accounts for the Exchase OÜ. Mar, 2021 - Deploy Android version to Google PlayMarket. Apr, 2021 - Margin trading. Jun, 2021- Crypto loans. Aug, 2021 - Crypto-wallet Jan, 2021 - Obtaining a license to work with virtual assets (cryptocurrency license). Jan, 2021 - Connection of liquidity providers, as part of the A-Book model implementation. Apr, 2021 - Deploy iOS version in AppStore. May, 2021 - Binary options. Jun, 2021 - Social trading
Team members & Advisors
Danila Prozorov- CEO Andrei Versilov- CTO Aditya Prakash-CMO
With the presence of technology in the financial industry, enabling many modern financial services which are very helpful for businesses or individuals in their financial activities - Exchase is a Fintech platform which will combine crypto exchange, social trading, binary options, a payment system, and an exchange. service, into a financial ecosystem that is modern, efficient, and safe for users. By using Exchase, users can save their funds because their money circulation is only on the Exchase platform and uses many financial services through 1 Exchase platform for many financial services.
For more information see the link below:
Website: https://exchase.io
White Paper: https://exchase.top/en/Exchase_WhitePaper_EN.pdf
Twitter: https://twitter.com/ExchaseF
Facebook: https: // www.facebook.com/ExchaseF
Telegram: https://t.me/exchase
Reddit: https://www.reddit.com/Exchase
Bitcointalk Username:Priya Chowdhury Telegram Username: @Yamini47 Bitcointalk url:https://bitcointalk.org/index.php?action=profile;u=2595077 Wallet address (eth):0xd9B445dA16B5a7b32792D01da5d620c6036BDD2D
submitted by Priya8180 to u/Priya8180 [link] [comments]

EBCC 2020 - European Breast Cancer Conference Latest Update

EBCC 2020 - European Breast Cancer Conference Latest Update

EBCC 2020 Annual Meeting
The EBCC 2020 Annual Meeting is being organized by the European Society of Breast Cancer Specialists and the EORTC Breast Cancer Group (BCG) to raise awareness in medicine and oncology through discussions on medical, safety, breast cancer, cancer and oncology issues.
The dates for the event were in March 2020, but due to the ongoing global issue and fight against the Coronavirus (COVID-19), the meet has been postponed. The Spanish Ministry of Health's announced that Spanish healthcare workers would not attend national or foreign conferences and the committee agreed for rescheduling the congress. This will now take place at the same venue in Barcelona from 30 September until 2 October 2020. The venue for the European Breast Cancer Conference will be the same is true where medical and oncological knowledge is generated by delegates from all over the world. The site is the Center de Convencions Internacional de Barcelona, Spain, where over 8,000 + participants from all over the world are expected to participate. Talking of this annual meeting's purpose and concept, this event is planned to create awareness and motivation.
The organizers feeling responsible towards the 2,500 healthcare workers who are expected to attend EBCC-12 decided to take this step. The organizer's main concern is for the safety and wellbeing of all our members and employees, as well as the broader community.
To mitigate the risk of further spreading COVID-19 and to reduce the number of people currently travelling between countries rescheduling the meet will avoid the risk of spread. While every session remains the same, as registered representatives all registration will be moved to the new date directly. Additionally, by 24 August 2020, registrations will stay open at a daily pace.

EBCC 2020 Annual meet Latest Update

The goal of the EBCC 2020 in Barcelona is to place the patient at the centre of all our activities and discussions and to deepen the role of multidisciplinary oncology in breast cancer by fostering participation and involvement among all oncology professions.
There will be diverse profiles of scientists, physicians, patient advocates and health care practitioners. The experience will tackle key concerns patients face in breast cancer travel continuum. A wonderful assembly invites the doctors, scientists, and patients to encourage the advancement of the best approach for prevention and cure in clinical study and practice.
There will be debate and discussion with speakers around the globe who will highlight and demonstrate the activity that will bring about the transition, making this new EBCC 2020 schedule another success. As the delegates expect this gathering for thousands, the congress has always provided a complex multidisciplinary atmosphere that provides the perfect climate for participants. It will help leverage knowledge, encourage education and create breast cancer awareness.

European Breast Cancer Conference 2020 info

Speaking about the EORTC Breast Cancer Community (BCG), it is a collective organization that seeks to challenge, redefine and enhance clinical methods in all controversial areas of breast cancer diagnosis and therapy, including unusual cases such as men's breast cancer. The company examines fast-term outcomes and records all patients before they die. Together these two organizations for the EBCC 2020 Annual meet Latest Update has strengthened and harmonized the level of patient care around the globe and are working toward identifying and promoting the most appropriate testing and treatment treatments, providing high-quality clinical breast service to all women, setting breast care standards.
This EBCC 2020 meeting invites the industry professionals to present to the world their inventions. Use this as an ability to share as many scheduled and improvised networking activities from side to side that will help you make new connections and improve existing ones. The annual congress is a collaborative initiative to improve and build up the skills, to encourage qualitative and quantitative understanding of the participants by enriching them with the new and most innovative discoveries and innovations.
It's necessary to understand the position of two vital sections of this EBCC congress before Hotel Reservations for EBCC 2020. The EUSOMA European Breast Cancer Society was founded as a non-profit organisation, back in 1986. The organization is committed to the diagnosis and treatment of breast diseases, particularly breast cancer. The group supports scientific science and aims to strengthen the ties between scientists and healthcare professionals.

Hotel Reservations for EBCC 2020 with Medconn

Chose Medconn for hotel reservations near EBCC 2020 Venue, and reserve your congress meeting seats.
Medconn offers conference rooms, airline terminal trading, transport management, and a comprehensive booking process for a wide range of events and individuals. There are intervention courses that include pre-congress meetings, post-conference meals, lodging and transportation, as well as excursions to the city. From securing your seats and get the best service for the annual EBCC 2020 meeting with Medconn. The Medconn provides a full travel package with online booking facilities that consolidate: Home, Dinner, Relevant Tax and WiFi.
Transportation and hotels close to the venue will save you time and allow you to discover all of the region's dropping attractions. For all social activities, air terminal markets and transport organization we help make your travel success.
Medconn provides comprehensive facilities from the date of arrival to the departure from an individual network to plan and organize congress voyages. The team is looking to build business partnerships and provide quality services for this new EBCC 2020 schedule with the best luxury or accessible hotel and travel support network.
Medconn has been the industry with the most confidence and reliability to book your spot. Working with an interconnected network of transportation networks, hotel platforms and much more, this is the one-stop centre for all your needs Concluding the assistance offered by Medconn, for this upcoming Medical Congress in San Diego, you can choose from booking the congress location, transfers, specialized meeting and the best Hotel Reservations for EBCC 2020.
submitted by CongressPlanner to u/CongressPlanner [link] [comments]

Khám phá những trải nghiệm du lịch thú vị tại Miami

Khám phá những trải nghiệm du lịch thú vị tại Miami
Với bầu trời xanh quanh năm, ánh nắng mặt trời cùng với màu nước trong xanh của vùng biển Caribbean, Miami - được xem là TP “ngầu” nhất bang Florida nước Mỹ - luôn sẵn sàng cho những ai muốn đến gần hơn với nó. Bất kỳ khi nào bạn đặt chân đến nơi này, thì chắc chắn đây là những thứ không thể bỏ lỡ trong danh sách những việc cần làm khi chuyến tham quan Miami. Đặt vé máy bay đi Mỹ giá rẻ 2020 đến với tại đây và du khách sẽ có cơ hội khám phá thêm nhiều điều hấp dẫn và quyến rũ Thả dáng ở bãi biển và hơn thế nữa Đã nói đến du lịch Mỹ thì khó lòng bỏ dở Miami, và đã nói đến Miami thì chắc chắn phải nhắc đến biển. Bờ biển Miami là nơi có đường bờ biển nổi tiếng nhất bang Florida, tọa lạc trên nền neon của con đường Ocean Drive. Khu Mid-Beach (nằm giữa đường 23 và 46) có những khu nghỉ mát rộng rãi, tránh xa khỏi sự ồn ào, nhộn nhịp của du khách. Dường như, Surfside và Sunny Isles nằm ở phía Bắc cung ứng những nơi nghỉ dưỡng cao hơn rất nhiều so với mặt nước.
Trong khi, nơi đây còn có các khu phố rất đáng để tìm hiểu như Coral Cables, Coconut Grove, Wynwood và Design District. Còn gì tuyệt vời hơn với khi có chuyến đi trong ngày đến Công viên quốc gia Everglades gần đó, nơi sẽ xong xuôi trải nghiệm Florida của khách tham quan bằng những chiếc thuyền máy và xem cá sấu. Đặt ve may bay di san francisco đến với khi đến đây và khách du lịch sẽ có cơ hội tìm hiểu thêm nhiều trải nghiệm đáng nhớ chuyến du lịch phòng trưng bày nghệ thuật Art Basel Miami Beach mang toàn cầu nghệ thuật đến Miami vào tháng 12, dù thành phố này có rất nhiều kết quả nghệ thuật và kiến ​​trúc lộng lẫy để thưởng thức cả năm, ngay cả trong các trung tâm buôn bán như Design District, Bal Harbor, trung tâm thương mại Lincoln Road và TTTM Aventura.
Brickell City Centre có một loạt các shop từ các thương hiệu châu Âu ít được biết đến, Trong khi Bảo tàng Khoa học Frost mới khiến trẻ em mến mộ tương tác với các triển lãm và cung thiên văn được mở cửa mỗi ngày trong năm. Bảo tàng Nghệ thuật Perez (PAMM) là nơi tổ chức các triển lãm nghệ thuật Caribbean và Mỹ Latinh. Trong khi khách du lịch có thể dành thời gian đến thăm một số bộ sưu tập cá nhân của thành phố này, bao gồm bộ sưu tập Marguiles tại Warehouse and the Rubell Museum. Mua vé máy bay đi Los Angeles đến với nơi đây và các bạn sẽ có cơ hội khám phá thêm nhiều điều thú vị và quyến rũ Thưởng thức ẩm thực Miami là một địa điểm thưởng thức ẩm thực hoàn hảo với các nhà hàng, quán bar và phòng ăn mới mở ra Dường như mỗi tuần. Những thứ mà bạn sẽ muốn thử ít nhất một lần bao gồm Joe's Stone Crab ở South Beach (mùa cua đá diễn ra từ giữa tháng 10 đến giữa tháng 5) và Michael's Genuine ở Design District. Một điểm khác biệt ở đây đó chính là bữa xế chiều được xem như một thế giới cạnh tranh ở Miami, vì khách du lịch sẽ cần đặt chỗ tại những điểm nhiều người biết đến nhất nơi đây như Yardbird và Mandolin.
Mặt khác hành khách có thể hòa nhập cùng với người dân địa phương tại các điểm đến như David's Cafecito, La Sandw Richie, Zak the Baker và Panther Coffee. Khách du lịch có thể diện một bộ quần áo hấp dẫn nhất của mình và đến vui chơi tại các địa điểm hàng đầu như Nobu Miami, Zuma và The Surf Club Restaurant của Thomas Keller. Hai địa điểm cho một trải nghiệm ở Miami mà không giống bất cứ nơi nào chính là 27 Restaurant & Bar, nơi đầu bếp Jimmy Lebron đưa nền văn hóa của Miami vào các món ăn hấp dẫn và bùng nổ với các nguyên liệu tươi sống của Florida. Khác lạ Kiki on the River - nhà hàng ngoài trời trong nhà trên sông Miami với căn phòng đầy cảm xúc và các món ăn Địa Trung Hải tuyệt vời cho một khí hậu ấm áp.
Để thưởng thức hương vị Cuba đặc trưng của thành phố, hãy đến với Calle Ocho ở Little Havana và thưởng thức nhạc sống và những ly mojito tại địa danh mang tính lịch sử Ball & Chain, cùng với những ly medianoche và colada (một loại cà phê Cuba ngọt ngào, được đựng trong một cốc nhựa nhỏ) tại Versailles hoặc La Carreta (cả hai đều có tại Sân bay Quốc tế Miami). Chơi với nước Không có chuyến đi nào đến Miami dứt mà không dành thời gian vui đùa với nước. Đây là một nơi tuyệt vời để tìm ra khía cạnh mạo hiểm của mình bằng những trò chơi như lướt ván, dù lượn hoặc lái cano.
Chèo thuyền kayak là những cách hấp dẫn để khám phá vịnh Miami, khác biệt tour du thuyền trên đảo Island Queen đến Stiltsville - một bộ sưu tập những ngôi nhà gỗ cũ trên biển, sẽ cho các bạn cơ hội chụp một số bức ảnh tuyệt vời và hòa mình với gió đại dương. Mua vé máy bay Vietnam Airline đến với nước Mỹ và khách tham quan sẽ có cơ hội khám phá thêm nhiều điều lôi cuốn Thả hồn trong khách sạn Ở Miami, các khách sạn là nơi mà khách tham quan có thể làm nhiều thứ hơn chỉ là đặt lưng xuống và nghỉ ngơi. Với 90 triệu USD được cải tạo trong nhiều năm, Ritz Carlton South Beach thanh lịch sau cuối đã mở cửa quay về. Đây là một tòa nhà mang tính bước ngoặt của kiến trúc sư nhiều người biết đến từ Art Deco - Morris Lapidus, bao gồm nhiều cụ thể nội thất nguyên bản. Trong đó nổi bật nhất là bức tường ánh sáng hình cầu mạ crôm ở sảnh gây được nhiều tuyệt vời.
Ở South Beach, những ai thích tiệc bể bơi thì đến Delano và LS South Beach. Ở Mid-Beach, Miami Beach EDITION cũng có tầng hầm gồm một hộp đêm với sân trượt băng trong nhà rộng 2.000m2 và sân chơi bowling với bốn làn. Ngay bên cạnh, khách du lịch sẽ tìm thấy một khách sạn mang tính biểu tượng khác đã được tân trang sang trọng, sang trọng hơn - Eden Roc Miami Beach. Điều khác biệt ở đây là nó có khách sạn lồng trong khách sạn - Nobu Miami Beach.
Hoặc nếu muốn một cái gì đó ngoạn mục hơn, khách tham quan có thể ở trong ngôi nhà cũ của Gianni Versace - Casa Casuarina, hoặc đến Surfside để thưởng thức sự hào nhoáng của Miami xưa tại The Four Seasons Surf Club. Mua vé máy bay đi Miami đến với tại đây và hành khách sẽ có cơ hội khám phá thêm nhiều điều thu hút và hấp dẫn
submitted by Huongcaobeo to u/Huongcaobeo [link] [comments]


Many of you have heard about the Binance exchange, which is currently the top! Their ICO was very successful! Binance held an ICO in July 2017, they raised about $ 15 million. Today it is the largest exchange in the world - with a turnover of 4.3 billion dollars. The price of the BNB token was equivalent to 43 US dollars at the initial cost of the coin 0.10 US dollars. You have the opportunity to earn your capital and pass by such an opportunity will be stupid !!! Your task is to read the article to the end (in order to understand what a large-scale project you have.) Many people managed to buy a C3 token for $ 1, and its price is already $ 4.30! The number of people on the exchange is already 1300 and this is the very beginning, all doors are open for you (trade, develop an affiliate network, participate in the promotion or simply register and get a 20% discount.) The entire C3 ecosystem: exchange, application, C3 card, partners account, token !!! The exchange works with several jurisdictions, covering the countries of the CIS, Asia, Europe and the Middle East, which will allow working with all participants in the financial market !!! Estonian jurisdiction it allows you to work all over the world! (License © C3EXCHANGE OÜ, No. 14733663 Estonia, Tallinn, Lasnamäe linnaosa, Punane tn 68-170, 13619; Licenses: FVR001114, FRK001004) Pass-through registration (sso) this allows you to register on the exchange or in another instrument once (and you are automatically registered in all services.) For professionals, there are trading tools (wallet trading, api-key trading, stop-limit orders.) Trust management - PAMM-ACCOUNTS (the function will be available in the summer of 2020) Commissions on the C3 Exchange can be paid both with cryptocurrency and tokens C3 The C3 token is used by default when paying commissions and gives the user a 50% discount Excellent exchange tools: trading traditional crypto assets (dollar, euro and others), BTC, ETH, LTC, C3. and this is just the beginning! -International bank card with cryptocurrency and cashback! - Debit, Credit and Crypto Bank Card! - Ability to pay for goods / services at points of reception VISA / Mastercard! - International CASHBACK from leading retailers in the world! - A mobile application and a mobile bank with the ability to exchange crypts for fiat and fiat for crypto! - Account in your own crypto-exchange of the project! - Exchange of 20 leading cryptocurrencies among themselves and for fiat money at the rate of less than 3% of exchange prices! - A liquid token for which you can not only order a card, but also use many services of the project! In the near future there will be an application for iOS and Android allowing customers to store and exchange foreign exchange assets! Already in December, the Android application comes out! A multi-currency card allows you to store both crypto and fiat funds. Any client will be able to open several accounts tied to different currencies and choose an “active account” with which he can make purchases. Pros: Storage and convection of currencies, issuance of a vertical card, cashback rewards, news and special offers! The best affiliate program! The exchange gives its partners 60% of the profits! 20% goes to you from the moment you verified on the exchange through simple registration and KYC!
Get a free package allows you to get 20% of the company's profits from your first level customers in C3 tokens From the first line! Now when your invitees are registered and also begin to invite partners, you get another 5%, to activate the 2nd and 3rd line you need to pay 50 C3 tokens (this way you will have a structure with three lines!) Who wants even more affiliate lines in depth can pay 300 C3 tokens and create the maximum affiliate network of 9 levels !!! If at the moment there is no possibility and you do not understand what your structure will be, then simply register and get 20%, in the future you will be able to see how many people you will invite and then decide for yourself whether you should open level 9 or you can limit yourself to 3 !! !
#C3exchange #C3 #TransFee #cryptocard #investments #income #exchanges #specifications #trade #CSS #CCCR #USSR #CryptoCreditCard #CryptoCreditCard #cashback #exchanger #crypto service #blockchain #crypto #technologies #real economy #money #mlm #network business #mlm #success #passive #income #business #network business
submitted by dimonbuton12 to u/dimonbuton12 [link] [comments]

40th EORTC-PAMM Winter Meeting. 06 Feb - 09 Feb 2019 Verona, IT. Abstract submission (deadline: 20th December 2018) Registration. More information on the conference website. Next events. EORTC Cancer in Elderly Task Force Virtual Meeting. November 13. Head and Neck Young Investigators Group Webinar. November 16. European Cancer Summit 2020. November 19. Free webinar: What is the future of ... February 13 - February 15, 2020 41st EORTC-PAMM Winter Meeting in Stockholm Oasmia was one of the official sponsors of the exciting 41st EORTC-PAMM Winter Meeting in Stockholm. EORTC-PAMM group Amsterdam, Noord-Holland, Nederland Pharmacologist at EORTC-PAMM 0 connectie Volledig profiel van EORTC-PAMM op LinkedIn en bekijken en connectie maken 41st EORTC –PAMM winter meeting: February 13th-15th, 2020 in Stockholm. Our group actively participated to the EORTC–PAMM winter meeting 2020.The meeting was organised by the PAMM Scientific Committee and by the local organizers Prof. Stig Linder and Dr. Padraig D’Arcy in the wonderful auditorium of Karolinska Institute. Acceptance notification was sent out 2020-01-10 If you haven´t received any notification please check your “spam” folder or contact [email protected] According to the tradition of the EORTC-PAMM group, abstracts from PhDs, Postdocs and clinical fellows are particularly welcome, and we will try to have many sessions for oral presentation and stimulate constructive discussion of these ...

[index] [6726] [12102] [13923] [944] [10356] [6453] [6672] [13483] [3722] [398]